1999
DOI: 10.1081/pdt-100101392
|View full text |Cite
|
Sign up to set email alerts
|

Enzymatic Degradation of Leuprolide in Rat Intestinal Mucosal Homogenates

Abstract: The purpose of this study was to evaluate in vitro enzymatic degradation and protection of leuprolide acetate in the mucosal homogenates of rat small intestine. When leuprolide was incubated at 37 degrees C with the homogenates, it was degraded quickly. The apparent Michaelis-Menten constant, K(m), and the maximal reaction velocity, Vmax, for leuprolide were 898 mM and 3.4 nmol/min/mg protein, respectively. At least four metabolites of leuprolide were observed in HPLC chromatograms, which were related to cleav… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2004
2004
2012
2012

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 10 publications
0
1
0
1
Order By: Relevance
“…1(A), is a synthetic nonapeptide and potent analog of GnRH that inhibits gonadotropin secretion, when given continuously, achieving castrate levels for testosterone in prostate cancer patients. As a peptide, leuprolide is susceptible to the action of proteolytic enzymes,6, 7 while proteases and peptidases act as barriers limiting its intestinal absorption 8. Leuprolide's bioavailability is low (less than 1%) following either oral or intraduodenal injections in male rats 9.…”
Section: Introductionmentioning
confidence: 99%
“…1(A), is a synthetic nonapeptide and potent analog of GnRH that inhibits gonadotropin secretion, when given continuously, achieving castrate levels for testosterone in prostate cancer patients. As a peptide, leuprolide is susceptible to the action of proteolytic enzymes,6, 7 while proteases and peptidases act as barriers limiting its intestinal absorption 8. Leuprolide's bioavailability is low (less than 1%) following either oral or intraduodenal injections in male rats 9.…”
Section: Introductionmentioning
confidence: 99%
“…Δζδζηυηενα, δ απμοζία D -αιζκμλζημφ ηαηαθμίπμο ζηδ εέζδ 6, υπςξ οπμζηδνίγεηαζ ηαζ αζαθζμβναθζηά (Berger et al, 1991;Matsoukas et al, 1997;Keramida et al, 1998;Keramida et al, 2006) Sealfon et al, 1997;Laimou et al, 2010 (Claassen, 1994) ηαζ (ii) θυβς απυηθζζδξ ηδξ πμνήβδζδξ απυ ημο ζηυιαημξ, ηαεχξ δ LHRH ηαζ ηα ακάθμβα αοηήξ παναηηδνίγμκηαζ απυ ζδζαίηενα παιδθή αζμδζαεεζζιυηδηα. Δίκαζ αθδεέξ πςξ δ πεπηζδζηή θφζδ ηδξ LHRH ηαζ ηςκ ακαθυβςκ αοηήξ ηαεζζηά ηα οπυ ιεθέηδ ιυνζα εοάθςηα οπυ ηδ δνάζδ εκυξ πθήεμοξ ζζημ -εζδζηχκ πνςηεμθοηζηχκ εκγφιςκ (Haviv et al, 1992;Zheng et al, 1999a).…”
Section: πεηξακαηηθή πνξείαunclassified